본문 바로가기
KERD
논문KCI 등재

The secondary prophylactic efficacy of beta-blocker after endoscopic gastric variceal obturation for first acute episode of gastric variceal bleeding

김영석|정승원|김홍수|김상균|김민진|장재영|서유리|이윤나|이세환|김부성|최문한
대한간학회 (The korean Association for the Study of the Liver)|2013.09|Clinical and Molecular Hepatology|제19권 제3호|pp. 280-287|DOI http://dx.doi.org/10.3350/cmh.2013.19.3.280

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

Secondary preventionGastric varicesBeta-blocker

초록

Background/Aims: The most appropriate treatment for acute gastric variceal bleeding (GVB) is currently endoscopic gastric variceal obturation (GVO) using HistoacrylⓇ. However, the secondary prophylactic efficacy of beta-blocker (BB)after GVO for the first acute episode of GVB has not yet been established. The secondary prophylactic efficacy of BB after GVO for the first acute episode of GVB was evaluated in this study. Methods: Ninety-three patients at Soonchunhyang University Hospital with acute GVB who received GVO using HistoacrylⓇ were enrolled between June 2001 and March 2010. Among these, 42 patients underwent GVO alone (GVO group) and 51 patients underwent GVO with adjuvant BB therapy (GVO+BB group). This study was intended for patients in whom a desired heart rate was reached. The rates of rebleeding-free survival and overall survival were calculated for the two study groups using Kaplan-Meyer analysis and Cox’s proportional-hazards model. Results: The follow-up period after the initial eradication of gastric varices was 18.14±25.22 months (mean±SD). During the follow-up period, rebleeding occurred in 10 (23.8%) and 21 (41.2%) GVO and GVO+BB patients,respectively, and 39 patients died [23 (54.8%) in the GVO group and 16 (31.4%) in the GVO+BB group]. The mean rebleeding-free survival time did not differ significantly between the GVO and GVO+BB groups (65.40 and 37.40months, respectively; P=0.774), whereas the mean overall survival time did differ (52.54 and 72.65 months,respectively; P=0.036). Conclusions: Adjuvant BB therapy after GVO using HistoacrylⓇ for the first acute episode of GVB could decrease the mortality rate relative to GVO alone. However, adjuvant BB therapy afforded no benefit for the secondary prevention of rebleeding in GV. (Clin Mol Hepatol 2013;19:280-287)

Abstract

Background/Aims: The most appropriate treatment for acute gastric variceal bleeding (GVB) is currently endoscopic gastric variceal obturation (GVO) using HistoacrylⓇ. However, the secondary prophylactic efficacy of beta-blocker (BB)after GVO for the first acute episode of GVB has not yet been established. The secondary prophylactic efficacy of BB after GVO for the first acute episode of GVB was evaluated in this study. Methods: Ninety-three patients at Soonchunhyang University Hospital with acute GVB who received GVO using HistoacrylⓇ were enrolled between June 2001 and March 2010. Among these, 42 patients underwent GVO alone (GVO group) and 51 patients underwent GVO with adjuvant BB therapy (GVO+BB group). This study was intended for patients in whom a desired heart rate was reached. The rates of rebleeding-free survival and overall survival were calculated for the two study groups using Kaplan-Meyer analysis and Cox’s proportional-hazards model. Results: The follow-up period after the initial eradication of gastric varices was 18.14±25.22 months (mean±SD). During the follow-up period, rebleeding occurred in 10 (23.8%) and 21 (41.2%) GVO and GVO+BB patients,respectively, and 39 patients died [23 (54.8%) in the GVO group and 16 (31.4%) in the GVO+BB group]. The mean rebleeding-free survival time did not differ significantly between the GVO and GVO+BB groups (65.40 and 37.40months, respectively; P=0.774), whereas the mean overall survival time did differ (52.54 and 72.65 months,respectively; P=0.036). Conclusions: Adjuvant BB therapy after GVO using HistoacrylⓇ for the first acute episode of GVB could decrease the mortality rate relative to GVO alone. However, adjuvant BB therapy afforded no benefit for the secondary prevention of rebleeding in GV. (Clin Mol Hepatol 2013;19:280-287)

참고문헌 (32)

  1. Sarin SK, "Gastric varices: profile, classification, and management", Am J Gastroenterol, 84, pp.1244~1249 (1989)
  2. Greig JD, "Management of gastric variceal haemorrhage", Br J Surg, 77, pp.297~299 (1990)
  3. Sarin SK, "Prevalence, classification and natural history of gastric varices: a longterm follow-up study in 568 portal hypertension patients", Hepatology, 16, pp.1343~1349 (1992)
  4. Hashizume M, "Classification of gastric lesions associated with portal hypertension", J Gastroenterol Hepatol, 10, pp.339~343 (1995)
  5. Ohnishi K, "Direction of splenic venous flow assessed by pulsed Doppler flowmetry in patients with a large splenorenal shunt. Relation to spontaneous hepatic encephalopathy", Gastroenterology, 89, pp.180~185 (1985)
  6. Trudeau W, "Endoscopic injection sclerosis in bleeding gastric varices", Gastrointest Endosc, 32, pp.264~268 (1986)
  7. Watanabe K, "Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and", or gastric varices using portal vein catheterization, 1988, pp.95, 434~440
  8. Thakeb F, "Endoscopic diagnosis of gastric varices", Endoscopy, 26, pp.287~291 (1994)
  9. Arakawa M, "Pathomorphology of esophageal and gastric varices", Semin Liver Dis, 22, pp.73~82 (2002)
  10. Ryan BM, "A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices", Gastroenterology, 126, pp.1175~1189 (2004)
  11. D’Amico G, "The treatment of portal hypertension: a meta-analytic review", Hepatology, 22, pp.332~354 (1995)
  12. de Franchis R, "Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension", J Hepatol, 53, pp.762~768 (2010)
  13. Soehendra N, "Endoscopic obliteration of large esophagogastric varices with bucrylate", Endoscopy, 18, pp.25~26 (1986)
  14. Sarin SK, "Endoscopic sclerotherapy in the treatment of gastric varices", Br J Surg, 75, pp.747~750 (1988)
  15. Shiha G, "Gastric variceal ligation: a new technique", Gastrointest Endosc, 49, pp.437~441 (1999)
  16. "Hepatology", 1988, 1348~
  17. Kanagawa H, "Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration", J Gastroenterol Hepatol, 11, pp.51~58 (1996)
  18. Huang YH, "Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety", Gastrointest Endosc, 52, pp.160~167 (2000)
  19. Akahoshi T, "Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience", Surgery, 131(Suppl), pp.S176~S181 (2002)
  20. 주현수, "위정맥류 치료에서 Histoacryl？ (N-butyl-2-cyanoacrylate) 주입술의 장기성적 보고 -10년 경험", 대한소화기학회지, 49(5), pp.320~326 (2007), 대한소화기학회
  21. Gonzalez R, "Meta-analysis: Combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis", Ann Intern Med, 149, pp.109~122 (2008)
  22. Pugh RN, "Transection of the oesophagus for bleeding oesophageal varices", Br J Surg, 60, pp.646~649 (1973)
  23. Kamath PS, "A model to predict survival in patients with end‐stage liver disease", Hepatology, 33, pp.464~470 (2001)
  24. Hwang SS, "N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding", J Comput Assist Tomogr, 25, pp.16~22 (2001)
  25. Tan YM, "Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate", Gastrointest Endosc, 55, pp.276~278 (2002)
  26. Jutabha R, "Randomized, prospective study of cyanoacrylate injection, sclerotherapy, or rubber band ligation for endoscopic hemostasis of bleeding canine gastric varices", Gastrointest Endosc, 41, pp.201~205 (1995)
  27. Sarin SK, "A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices", Am J Gastroenterol, 97, pp.1010~1015 (2002)
  28. Lo GH, "A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices", Hepatology, 33, pp.1060~1064 (2001)
  29. 김문영, "Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data", Clinical and Molecular Hepatology, 19(1), pp.36~44 (2013), 대한간학회
  30. Mahadeva S, "Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding", Am J Gastroenterol, 98, pp.2688~2693 (2003)
  31. Mishra SR, "Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial", Gut, 59, pp.729~735 (2010)
  32. 김재우, "위정맥류 출혈 환자에서 N-butyl-2-cyanoacrylate를 이용한 내시경경화요법의 치료 효과", Clinical and Molecular Hepatology, 12(3), pp.394~403 (2006), 대한간학회

관련 논문AI추천

Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data고문수, 권소영, 김동준, 김문영, 김병석, 김병호, 김상균, 김영석, 김진동, 김태엽, 김태효, 박성재, 박수영, 박승하, 백순구, 서연석, 손주현, 심재준, 엄순호, 이정일, 이준성, 이진우, 이창형, 이태희, 이현웅, 임영석, 장병국, 장재영, 정승원, 조용균, 조은영, 천갑진, 최원혁, 최창수, 한상영, 황재석대한간학회 · Clinical and Molecular Hepatology2013 · 제19권 제1호The comparison of esophageal variceal ligation plus propranolol versus propranolol alone for the primary prophylaxis of esophageal variceal bleedi고광철, 곽금연, 백승운, 백용한, 유병철, 이준혁, 제동모, 최문석대한간학회 · Clinical and Molecular Hepatology2014 · 제20권 제3호Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach김용권, 김지훈, 김태형, 박상정, 박승운, 변관수, 서상준, 서연석, 안형인, 엄순호, 연종은, 이한아, 임형준, 장재영, 정영걸대한간학회 · Clinical and Molecular Hepatology2016 · 제22권 제4호Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study권영오, 김상균, 김영석, 김정한, 김태엽, 박수영, 손주현, 이재명, 장세영, 정재윤, 조창민, 최원혁, 탁원영, Byung Chul Yoo, Dae Yong Kim, Go Heun Kim, Hong Joo Kim, Jae Wan Lim, Joon Hyeok Lee, Se-Ok Lee, Seung Woon Paik, So Young Kwon, Yang Won Min, Yong Kyun Cho, Yu Hwa Lee대한간학회 · Clinical and Molecular Hepatology2012 · 제18권 제4호Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?김가람, 김현수, 박선영, 박창환, 위진우, 유종선, 이완식, 전충환, 조규만, 조성범, 주영은, 최성규대한내과학회 · The Korean Journal of Internal Medicine2015 · 제30권 제5호정맥류 출혈의 일차 예방으로서 예방적 내시경적 결찰술과 Propranolol의 비교김윤홍, 김재선, 김효정, 박영태, 박종재, 변관수, 연종은, 이창홍, 정길만, 조남영대한소화기내시경학회 · Clinical Endoscopy2002 · 제25권 제1호

이 간행물의 다른 논문 (7건)

Elevated red cell distribution width is associated with advanced fibrosis in NAFLD조용균, 김홍주, 김범수, 주관중, 박동일, 박정호, 김창준, 김용성, 김병익, 손정일, 허원재, 최원석, 전우규, 김화목pp. 258-265Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea이승민, 장은철, 전대원, 조용균, 정은행, 최영길, 유승호pp. 266-272Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients권소영, 최원혁, 김정한, 고순영, 이창훈pp. 273-279Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as firstline therapy이시형, 이헌주, 오명진pp. 288-299Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients김영집, 김기찬, 조성원, 정재연, 황선혁, 김순선, 이다미pp. 300-304
원문 보기